HCA Healthcare (NYSE:HCA) will issue its quarterly earnings data before the market opens on Monday, January 29th. Analysts expect the company to announce earnings of $1.93 per share for the quarter. HCA Healthcare has set its FY17 guidance at $6.45-6.70 EPS.
HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, October 31st. The company reported $1.21 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $1.21. HCA Healthcare had a net margin of 6.13% and a negative return on equity of 47.16%. The business had revenue of $10.70 billion for the quarter, compared to analyst estimates of $10.70 billion. During the same period in the previous year, the business posted $1.45 earnings per share. The business’s revenue was up 4.1% compared to the same quarter last year. On average, analysts expect HCA Healthcare to post $7 EPS for the current fiscal year and $7 EPS for the next fiscal year.
HCA Healthcare (NYSE HCA) opened at $93.01 on Monday. HCA Healthcare has a one year low of $71.18 and a one year high of $93.32. The company has a current ratio of 1.68, a quick ratio of 1.41 and a debt-to-equity ratio of -6.46. The stock has a market cap of $33,600.00, a PE ratio of 13.23, a PEG ratio of 1.23 and a beta of 0.55.
HCA has been the topic of a number of recent analyst reports. Morgan Stanley lowered shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $85.00 price target on the stock. in a research note on Wednesday, December 20th. Credit Suisse Group reiterated an “outperform” rating and set a $25.00 price target on shares of HCA Healthcare in a research note on Tuesday, December 26th. KeyCorp reiterated an “overweight” rating and set a $90.00 price target (down from $95.00) on shares of HCA Healthcare in a research note on Thursday, October 19th. Citigroup upgraded shares of HCA Healthcare from a “neutral” rating to a “buy” rating in a research note on Tuesday, December 12th. Finally, Cantor Fitzgerald reiterated a “buy” rating and set a $90.00 price target on shares of HCA Healthcare in a research note on Tuesday, October 31st. Three investment analysts have rated the stock with a sell rating, six have issued a hold rating and seventeen have given a buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $88.32.
TRADEMARK VIOLATION WARNING: “HCA Healthcare (HCA) Scheduled to Post Quarterly Earnings on Monday” was reported by American Banking News and is the sole property of of American Banking News. If you are viewing this report on another site, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this report can be viewed at https://www.americanbankingnews.com/2018/01/22/hca-healthcare-hca-scheduled-to-post-quarterly-earnings-on-monday.html.
About HCA Healthcare
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.